Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

China · Delayed Price · Currency is CNY

6.80

+0.16 (2.41%)

Feb 4, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Respiratory Medicine	1.14B
Respiratory Medicine Growth	22.26%
Digestive System Medicine	400.14M
Digestive System Medicine Growth	10.50%
Other Drugs	218.05M
Other Drugs Growth	135.87%
Systemic Anti-infective Drugs	146.63M
Systemic Anti-infective Drugs Growth	14.75%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	1.91B
China Growth	25.75%